Home > Press > New Nanomaterial for regenerative medicines at SMi’s Pharmaceutical Nanotechnology conference
Abstract:
Nanotechnology is a multidisciplinary scientific field that is currently undergoing explosive development. Nano-enhanced medicines are opening new opportunities for therapeutic delivery and targeting technology
New Nanomaterial for regenerative medicines at SMi’s Pharmaceutical Nanotechnology conference
London, UK | Posted on March 27th, 2011
Join SMi at their inaugural case study driven conference that will address not only the latest scientific developments, but also the know-how required to successfully translate these discoveries and technologies into a commercially successful product.
Come and hear key presentations from the top 50 pharma companies that include:
The business case for nanotechnology
Thomas Keller, Director, Open Innovation, GlaxoSmithKline
Miniaturisation and modelling of beads milling
Mostafa Nakach, Head of Pharmaceutical Engineering Group, Sanofi-Aventis R&D
Investigation of chitosan nanoparticle formulations
Michael Keller, Senior Fellow, siRNA Project Leader, Technical Research and Development (TRD), Novartis Pharma
Enabling oncology drug development with nanotechnology
Henry Havel, Senior Research Fellow, Product Research and Development, Eli Lilly and company
Industry partnering opportunities, open innovation, one solution
Peter Luke, Senior Director, R&D Business Development, Worldwide Business Development, Pfizer
####
About SMi
Pharmaceutical Nanotechnology: Applications & Commercialisation is just one of the many conferences that are a part of the SMi Group portfolio.
The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi’s highly targeted conferences, workshops and publications. For more information visit www.smi-online.co.uk
For more information, please click here
Contacts:
Zain Philbey
+44 0 207 827 6722
Copyright © SMi
If you have a comment, please
Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
News and information
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
Nanomedicine
3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
Announcements
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
Events/Classes
Research and industry frontrunners gather in Dublin at the EuroNanoForum, Europe’s largest nanotechnology conference June 18th, 2013
Discover the ‘Nanostructure Advantage’ at ECerS 2013, Booth 5: Innovnano presents nanostructured powders for high performance ceramics June 17th, 2013
SEMATECH to Address Critical Supply Chain Challenges and Present Latest Technology Advances at SEMICON West 2013 June 17th, 2013
Imec shows multiple enhancement options for next-generation FinFETs: Leading nano-electronics R&D center addresses key challenges of Germanium finFET technology at VLSI 2013 June 14th, 2013